Schlotter Florian, de Waha Suzanne, Eitel Ingo, Desch Steffen, Fuernau Georg, Thiele Holger
University of Leipzig - Heart Center, Leipzig, Germany.
EuroIntervention. 2016 May 17;12(1):94-102. doi: 10.4244/EIJV12I1A17.
Interventional closure of post-myocardial infarction ventricular septal defects (VSD) is an alternative treatment option to surgical repair. However, only limited evidence exists concerning the interventional closure of a VSD. This review seeks to establish an overview of the existing literature and to carry out a systematic analysis of the success rate and clinical outcome of this procedure.
We conducted a comprehensive systematic literature search to evaluate the existing evidence of percutaneous device closure of post-infarction VSD. Patient series with fewer than five reported cases were excluded. In total, 13 series were identified, with an overall inclusion of 273 patients. Mean patient age was 70 years. Cardiogenic shock was present in 48% of cases at the time of intervention. Device closure within the first 14 days (acute phase) after VSD detection was performed in 42% of cases. Technical success rate was high (>75%). Successful device implantation rate was 89%. Overall in-hospital/30-day mortality was 32%. Major complications included device embolisation, ventricular perfora-tion and arrhythmias.
Percutaneous device closure of post-myocardial infarction VSD is a valuable alternative to surgical repair, with the advantage of immediate shunt reduction to prevent haemodynamic deterioration. A high rate of technically successful percutaneous procedures can be achieved; however, the mortality rate remains high, especially in cardiogenic shock patients.
心肌梗死后室间隔缺损(VSD)的介入封堵是外科修复的一种替代治疗选择。然而,关于VSD介入封堵的证据有限。本综述旨在对现有文献进行概述,并对该手术的成功率和临床结果进行系统分析。
我们进行了全面的系统文献检索,以评估经皮装置封堵心肌梗死后VSD的现有证据。报告病例少于5例的患者系列被排除。总共确定了13个系列,共纳入273例患者。患者平均年龄为70岁。48%的病例在干预时出现心源性休克。42%的病例在VSD检测后的前14天(急性期)内进行了装置封堵。技术成功率较高(>75%)。成功植入装置的比例为89%。总体住院/30天死亡率为32%。主要并发症包括装置栓塞、心室穿孔和心律失常。
经皮装置封堵心肌梗死后VSD是外科修复的一种有价值的替代方法,其优点是能立即减少分流以防止血流动力学恶化。经皮手术可实现较高的技术成功率;然而,死亡率仍然很高,尤其是在心源性休克患者中。